Asuka Pharmaceutical Holdings Inc.
あすか製薬ホールディングス株式会社
ASKA Pharmaceutical Holdings Co., Ltd. Alias
2021-04-01
TYO
Japan
Management of group companies
2-5-1 Shibaura, Minato-ku, Tokyo 108-8532, Japan
Zōdai Yamaguchi
1,197,900,000 JPY (11 100 millionJPY)
80 people
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
あすか製薬 IRニュース
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
あすか製薬 有価証券報告書・四半期報告書
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
あすか製薬 株主通信(報告書・中間報告書)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
あすか製薬 決算短信・決算説明会
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
CACEIS BANK, LUXEMBOURG BRANCH/AIF CLIENTS ASSETS
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
NAVF SELECT LLC
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
NOMURA PB NOMINEES LIMITED OMNIBUS MARGIN(CASHPB)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder
山口 隆
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Shareholder

51 entries
DateDescription
1893 Founder Yamaguchi Hachijūhachi opened the import business 'Yamaguchi Hachijūhachi Shōten' for foreign liquors and food products.
1893 Founder Yamaguchi Hachijūhachi opened the import business 'Yamaguchi Hachijūhachi Shōten' for foreign liquors and food products.
1908 Established the 'Teikoku-sha Food Division Factory' in Yokohama, producing and selling Japan's first artificial butter (margarine).
1908 Established the 'Teikoku-sha Food Division Factory' in Yokohama, producing and selling Japan's first artificial butter (margarine).
1920-06-16 The company established its founding date as June 16, 1920, the day it began manufacturing the male hormone drug 'Spelmin'.
1920-06-16 Founded the Teikoku-sha Organ Drug Research Institute based on the idea of creating useful medicines from animal organs, and began manufacturing the male hormone drug 'Spelmin'. This was deemed the founding of the company.
1920-06-16 Established the company on June 16, 1920, by founding the Teikoku-sha Organ Drug Research Institute within the Teikoku-sha Food Division Factory and beginning production of the male hormone drug 'Spelmin'.
1920-06-16 Founded the Teikoku-sha Organ Drug Research Institute within the Teikoku-sha Food Division Factory and began manufacturing the male hormone drug 'Spelmin', which was deemed the founding date of the company.
1929-06 Changed to a stock corporation and was named 'Teikoku-sha Organ Drug Research Institute Inc.'.
1936-01 Established a new Takatsu factory (Kawasaki Research Institute) in Takatsu-cho, Tachikawa-gun, Kanagawa Prefecture (now Takatsu-ku, Kawasaki City).
1945-10 Moved headquarters to Kawaguchi, Kawasaki City (within Takatsu factory premises) and renamed the company to Teikoku Organ Pharmaceutical Co., Ltd.
1946-10 Moved headquarters to Sakuma-cho, Shiba-nan, Minato-ku, Tokyo.
1949-06 Established a branch office in Osaka.
1955-09 Listed shares on the Tokyo Stock Exchange.
1957-05 Established a branch office in Fukuoka.
1957-07 Established a branch office in Nagoya.
1958-06 Established a branch office in Sapporo.
1962-08 Established a sales office in Tokyo.
1962-11 Moved headquarters to 2-5-1 Akasaka, Minato-ku, Tokyo.
1967-06 Established branch offices in Sendai and Hiroshima.
1969-06 Completed a new research building on the Kawasaki Research Institute site.
1970-06 Established a branch office in Yokohama.
1980-04 Established a new Iwaki factory.
1987-04 Established a sales office in Kyoto.
1991-05 Established Medical System Service Kanagawa Inc. (now Asuka Pharmaceutical Medical Inc.) as a consolidated subsidiary.
1993-09 Reclassified to the First Section of the Tokyo Stock Exchange.
1997-04 Established an international expatriate office in Frankfurt.
2001-09 Moved headquarters to 2-5-1 Shibaura, Minato-ku, Tokyo.
2005-02 Approved a merger agreement with Grelan Pharmaceutical Co., Ltd.
2005-10 Merged with Grelan Pharmaceutical Co., Ltd. and changed the company name to Asuka Pharmaceutical Co., Ltd.
2008 Established by renaming and merging from Medical System Service Kanagawa Inc.
2008 Renamed and merged from Medical System Service Kanagawa Inc., establishing Asuka Pharmaceutical Medical Inc.
2009-04 Established Asuka Actavis Pharmaceutical Co., Ltd.
2013 Established a separate company for the animal health business of Asuka Pharmaceutical (formerly Teikoku Organ Pharmaceutical).
2013 Separated the animal health business of Asuka Pharmaceutical (formerly Teikoku Organ Pharmaceutical) and established Asuka Animal Health Co., Ltd.
2013-06 Established Asuka Animal Health Co., Ltd. (consolidated subsidiary).
2017-04 Absorbed and merged Asuka Actavis Pharmaceutical Co., Ltd.
2018-10 Jointly invested in NeoASKA Pharma Private Limited in India with Omnicare Drugs India Private Limited.
2020 Established the 'Health Lab Mint+' for women as part of social contribution activities on the company's 100th anniversary.
2020 Moved to the Shonan Health Innovation Park in Fujisawa City, Kanagawa Prefecture, specializing in testing services.
2020 Established the 'Health Lab Mint+' for women to commemorate the 100th anniversary of Asuka Pharmaceutical.
2020-04 Moved Kawasaki Research Institute (Kawasaki City, Kanagawa Prefecture) to Shonan Research Institute (Fujisawa City, Kanagawa Prefecture).
2021-01 Invested in Ha Tay Pharmaceutical Joint Stock Company in Vietnam (equity method affiliate).
2021-04 Asuka Pharmaceutical Co., Ltd. established this company through a standalone share transfer, and its shares were listed on the First Section of the Tokyo Stock Exchange (Asuka Pharmaceutical Co., Ltd. was delisted in March 2021). Additionally, it acquired all shares of Asuka Animal Health Co., Ltd. and Asuka Pharmaceutical Medical Inc. held by Asuka Pharmaceutical Co., Ltd. through a stock dividend, making them direct subsidiaries.
2021-04 Invested in Nihon Glass Industry Co., Ltd. (equity method affiliate).
2021-04 Established a London office.
2021-04 Asuka Pharmaceutical Co., Ltd. established this company through a standalone share transfer, and its shares were listed on the First Section of the Tokyo Stock Exchange (Asuka Pharmaceutical Co., Ltd. was delisted in March 2021).
2021-04 Acquired all shares of Asuka Animal Health Co., Ltd. and Asuka Pharmaceutical Medical Inc. held by Asuka Pharmaceutical Co., Ltd. through a stock dividend, making them direct subsidiaries.
2021-04 The birth of Asuka Pharmaceutical Holdings Inc.
2022-04 Moved from the First Section to the Prime Market of the Tokyo Stock Exchange due to a review of market classifications.
2025-02 Made Ha Tay Pharmaceutical Joint Stock Company a consolidated subsidiary.
+ Loaded when opened
8010401159328
Trade nameあすか製薬ホールディングス株式会社
Trade name (kana)アスカセイヤクホールディングス
Name in English
Corporation type301
Address〒108-0023 東京都港区芝浦2丁目5番1号
Postal code1080023
Prefecture code13
City code103
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date2021-04-09
Update date2021-04-09
Change date2021-04-09
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record1
Excluded from search0
Processing type01
Correction type0
Trade name image ID
Address image ID
Sequence number2346410
Source: National Tax Agency Corporate Number Publication Site, basic three items
8010401159328
Corporate number8010401159328
Trade nameあすか製薬ホールディングス株式会社
Trade name (kana)アスカセイヤクホールディングス
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address東京都港区芝浦2丁目5番1号
Postal code1080023
Prefecture東京都
Prefecture code13
City or district港区
City code103
Street address芝浦2丁目5番1号
Organisation type301
Processing type01
Correction type0
Status
Representative代表取締役社長  山口 隆
Capital1197000000
Employees80
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date2021-04-09
Key information8010401159328
Source: gBizINFO (Ministry of Economy, Trade and Industry)
2026-09-22 02:34 (Model: gpt-4.1-nano )
↑